Qiang Li
About Qiang Li
Qiang Li is a scientist at Bristol Myers Squibb in New Brunswick, New Jersey, with extensive experience in analytical chemistry and drug development. He holds a PhD in Chemistry/Chemical Biology from the University of Florida and has authored nine peer-reviewed publications.
Current Position at Bristol Myers Squibb
Qiang Li is currently employed as a Scientist at Bristol Myers Squibb located in New Brunswick, New Jersey, United States. His role involves extensive research and development efforts in the pharmaceutical industry, leveraging various advanced analytical chemistry techniques.
Previous Roles at University of Florida
At the University of Florida, Qiang Li held several positions. He worked as a Teaching Assistant from 2020 to 2021 and from 2015 to 2016. He also served as a Graduate Research Assistant from 2015 to 2021. Additionally, he was the Hazardous Waste Manager at the Bruner Research Group from 2016 to 2019. These roles involved various responsibilities from assisting with teaching and conducting research to managing hazardous materials in the laboratory.
Education and Academic Background
Qiang Li earned his Doctor of Philosophy (PhD) in Chemistry/Chemical Biology from the University of Florida, completing his studies from 2015 to 2021. Prior to that, he obtained a Bachelor's degree in Pharmaceutical Engineering from Wuhan University of Technology, which he attended from 2008 to 2012. His foundational education was completed at Nanning No.2 High School from 2005 to 2008.
Research and Publications
Qiang Li has made significant contributions to scientific research, authoring nine peer-reviewed publications in high-impact journals. His research activities have been presented at renowned international conferences. His extensive hands-on experience includes peptide synthesis, in vitro transcription, and assay development using HPLC/LC-MS techniques.
Technical Expertise and Skills
Qiang Li possesses advanced expertise in a variety of analytical chemistry techniques such as FPLC, HPLC, LC-MS, and GC-MS. He has developed a new HILIC HPLC method for DTPA quantitation in high protein concentration mAb formulations and monitored the degradation of surfactant PS80 in drug substances using LC-MS. He is also proficient in protein refolding from inclusion bodies, modern protein purification, and chromatography techniques. Additionally, he excels in crystallography software and structure-based protein analysis.